Island Pharmaceuticals Ltd

CAMBERWELL, C3 · Founded 2020 · CIK 0002012855 · Biotech · Public

Repurposed and novel small-molecule drugs for viral infection prevention and treatment

islandpharmaceuticals.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.2M
1 Form D · Jun 2024
28 months since last filing
Contracts
—
No federal contracts on record
Patents
3
2 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,224,405
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2561Mountain Valley MD Holdings Inc.—$1.4M
2562STATEGICS, INC.——
2563Sentia Medical Sciences, Inc.——
2564Island Pharmaceuticals Ltd—$1.2M
2565LactaLogics, Inc.—$1.1M
2566MUCOMMUNE, LLC——
2567Ichor Microbial Solutions, Inc.—$1.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • David BrookesDirector
  • David FosterDirector
  • Albert HansenDirector
  • Paul MacLemanDirector
  • Nick McCoyExecutive Officer

Patents

USPTO · 2 granted of 3

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.